PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT: RESULTS FROM THE HOVON‐109 STUDY
Straten, L., Hosnijeh, F., Straten, L., Kater, A.P., Oers, M.H., Posthuma, W.F., Chamuleau, M.E., Nijland, M., Hoogendoorn, M., De Croon, F., Wittebol, S., Kerst, J., Marijt, E.W., Raymakers, R.A., Koene, H.R., Dobber, J.A., Tonino, S.H., Kersting, S.S., Langerak, A.W., Levin, M.
Published in Hematological oncology (01.06.2019)
Published in Hematological oncology (01.06.2019)
Get full text
Journal Article
PS1141 PROTEOMICS MARKERS PROGNOSTIC FOR OUTCOME OF CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS UNDER TREATMENT; RESULTS FROM THE HOVON‐109 STUDY
Hosnijeh, F. Saberi, Kater, A.P., Oers, M.H., Posthuma, W.F., Chamuleau, M.E., Nijland, M., Doorduijn, J.K., Gelder, M., Hoogendoorn, M., De Croon, F., Wittebol, S., Kerst, M., Marijt, E.W., Raymakers, R.A., Koene, H.R., Schaafsma, M.R., Dobber, J.A., Tonino, S.H., Kersting, S.S., Langerak, A.W., Levin, M.‐D.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article